Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss.

Trial Profile

Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Mirtazapine (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2013 Results presented at the Digestive Disease Week 2013.
    • 12 Nov 2010 Additional lead trial centre and investigator (Tack J), actual initiation date (September 2006) and planned end date (December 2011) identified as reported by ClinicalTrials.gov.
    • 12 Nov 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top